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early-onset osteoarthritis 
originates at the chondrocyte level 
in Hip Dysplasia
paula A. Hernandez  1*, Joel Wells1, emiliya Usheva1, paul A. nakonezny2, Zahra Barati1, 
Roberto Gonzalez1, Layla Kassem1 & frances M. D. Henson3
Subjects with developmental dysplasia of the hip (DDH) often show early-onset osteoarthritis (oA); 
however, the molecular mechanisms underlying this pathology are not known. We investigated 
whether cellular changes in chondrocytes from oA cartilage can be detected in chondrocytes from 
DDH cartilage before histological manifestations of degeneration. We characterized undamaged and 
damaged articular cartilage from 22 participants having hip replacement surgery with and without 
DDH (9 DDH-OA, 12 OA-only, one femoral fracture). Tissue immunostaining revealed changes in 
damaged oA-only cartilage that was also found in undamaged DDH-oA cartilage. chondrocytes in situ 
from both groups show: (i) thicker fibers of vimentin intermediate filaments, (ii) clusters of integrin 
α5β1, (iii) positive MMP13 staining and (iv) a higher percentage of cells expressing the serine protease 
HtrA1. Further characterization of the extracellular matrix showed strong aggrecan and collagen II 
immunostaining in undamaged DDH cartilage, with no evidence of augmented cell death by activation 
of caspase 3. These findings suggest that early events in DDH cartilage originate at the chondrocyte 
level and that DDH cartilage may provide a novel opportunity to study these early changes for the 
development of therapeutic targets for oA.
Although aging is among the various factors associated with the development of Osteoarthritis (OA)1, the inci-
dence of OA has been increasing in younger populations. One study projected that the percentage of patients 
younger than 65 years old requiring total hip arthroplasty would increase from 41% in 2006 to 52% in 20302. 
These younger patients have a number of etiologies, including those with developmental dysplasia of the hip 
(DDH). In this condition, abnormal biomechanics leads to anomalous stress distribution within the hip joint and 
subsequent damage to the joint tissues including articular cartilage3–6 and DDH is considered to be part of the 
congenital-biomechanical causes of OA7.
Chondrocytes, the cells of cartilage, are metabolically stimulated by different forms of mechanical loading 
including strain, shear, compression, tension, and hydrostatic loads, all of which are related to the structural 
and mechanical integrity of the joint. At the tissue-level, the extracellular matrix (ECM)8, composed mostly of 
collagen II and proteoglycans, gives mechanical integrity, while at the cellular-level the cytoskeleton fulfills this 
role, with vimentin intermediate filaments playing a major function9,10. Mechanical load, in turn, regulates both 
cytoskeleton dynamics11,12 and the synthesis of key ECM proteins13,14.
Of the key ECM components regulating mechanical signals to chondrocytes, fibronectin mediates pathways 
associated with cell growth and survival, for example promoting chondrocyte survival via integrin α5β1 binding15. 
However, in contrast, fibronectin fragments, produced via cleavage by proteases such as the High-Temperature 
Requirement protein A1 (HtrA1)16, activate catabolic pathways17,18. In OA, HtrA1 is upregulated in cartilage 
and synovial fluid in both human16,19 and murine joints20–23. HtrA1 was detected early in the process of cartilage 
degeneration21, and its primary function is believed to be the digestion of fibronectin and other proteins from 
both the pericellular matrix (PCM) and the ECM16,19,22. Disruption of the PCM may expose collagen II to bind 
the Discoidin Domain Receptor 2 (Ddr2)21 and consequently upregulate the matrix metalloprotease MMP1324, 
which has been most studied for its role in matrix degradation and the progression of OA25–28. MMP13 was found 
upregulated at early stages of cartilage degeneration in a rat model of DDH29.
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While it is apparent that altered hip biomechanics leads to early-onset OA in patients with DDH, the exact 
mechanism by which this occurs in not known. We hypothesize that the microenvironment in histologically 
undamaged DDH cartilage induces OA-like phenotypic adaptations in chondrocytes. Our results revealed that in 
cartilage from histologically undamaged regions in hips taken from patients with DDH, the chondrocyte pheno-
type had marked similarities to the pathological characteristics found in damaged OA hip cartilage from patients 
without DDH (OA-only), which reflect the usual population of patients. We propose that significant cellular 
changes precede histological manifestations of OA in DDH cartilage pointing toward alterations at the chondro-
cyte microenvironment level as an early mechanism underlying the aetiopathogenesis of OA in hip dysplasia.
Methods
ethics. All samples used in this study were obtained from patients (n = 22) having hip replacement surgery at 
Zale Hospital in UT Southwestern Medical Center, Dallas, TX. All patients gave informed consent to participate 
in this study and to collect de-identified medical waste. Study protocol, consent, and HIPAA were approved by 
the UT Southwestern Institutional Review Board (IRB). All methods were performed in accordance with relevant 
guidelines and regulations.
patients. Two groups of patients were identified. Twelve patients had OA with no history of DDH (40–
71 y.o; 7 female, 5 male), and 9 patients had OA secondary to DDH (23–72 y.o; 5 female, 4 male). In addition, we 
included undamaged cartilage from the hip of one non-OA patient (femoral fracture (female, 79 y.o.) was used 
for the patient independent analysis. Diagnosis was made using hip radiography by an Orthopaedic surgeon 
with subspecialty training in hip dysplasia and hip preservation. Exclusion criteria were any history of cancer or 
rheumatoid arthritis.
Experimental groups. The groups analyzed in this study were: (i) undamaged cartilage from OA-only, 
(ii) damaged cartilage from OA-only, (iii) undamaged cartilage from DDH-OA, and (iv) damaged cartilage 
from DDH-OA group. The femoral fracture case was considered undamaged cartilage and analyzed within the 
OA-only group.
cartilage harvest. Full-thickness cartilage without subchondral bone from both visibly undamaged and 
damaged areas of femoral heads were obtained from the femoral head using sharp dissection. Samples were 
fixed in 10% Neutralized Buffer Formalin and processed for paraffin embedding. Cartilage fibrillation was not 
homogeneous throughout the femoral heads, allowing us to collect areas with little to no damage and areas with 
a diverse degree of damage.
Histological staining, scoring, and immunohistochemistry. Cartilage slides of 5 µm thickness were 
obtained from paraffin-embedded blocks. Slides were deparaffinized and processed for Safranin-O staining. 
Images of this staining were used for tissue grading with a modified Mankin score30. The modified Mankin score 
(MMS) system that we used excluded the score allocated to ‘tidemark’ as subchondral bone was not collected dur-
ing sample acquisition, leading to a scale of 0 (no damage) to 13 (severe OA). Based on histological evidence of 
cartilage damage (reduced proteoglycan staining and surface fibrillation) we grouped samples into ‘undamaged’ 
(MMS ≤ 4) and ‘damaged’ cartilage (MMS > 4). This classification includes early and mild OA in the undamaged 
group, and moderate and severe in the damaged group31. Two blind investigators performed the scoring. For 
immunohistochemistry, antigen retrieval was not required for HtrA1, actin, caspase-3 active, and integrin α5β1 
staining. For vimentin, DeCal retrieval solution was used following the manufacturer’s instructions (BioGenex, 
HK089-5K). For MMP13, Aggrecan and Collagen II, antigen retrieval was done by 30 min incubation with 100 
mU/ml of Chondroitinase ABC (Sigma-Aldrich, C3667) in 50 mM Tris-HCl + 60 mM sodium acetate, pH 8.0, 
washed twice for 2 min with PBS, followed by 30 min incubation with 2 mg/ml of Hyaluronidase (Sigma-Aldrich, 
H3506) in PBS and 2 washes for 2 min with PBS. Both enzymatic incubations were done at 37 °C. Slides for HtrA1, 
actin, vimentin, integrin α5β1 and caspase 3 active were permeabilized with 0.5% Triton-X100 for 5 min. All 
slides were blocked for 2 hours at room temperature in blocking buffer (TBS with 5% BSA, 10% goat serum and 
0.1% Tween-20), followed by overnight incubation at 4 °C with the following antibodies prepared in TBS + 5% 
BSA + 0.1% Tween-20: rabbit anti-HtrA1 (Abcam, ab38611; 1:100), mouse anti-actin (Abcam, ab8226; 1:100), 
mouse anti-integrin α5β1 (EMD Millipore, MAB1969; 1:100), rabbit anti-vimentin (Abcam, ab45939; 1:100), 
rabbit anti-MMP13 (Abcam, ab39012; 1:200), mouse anti-Aggrecan (Abcam, ab3778; 1:100), rabbit anti-collagen 
II (Abcam, ab34712; 1:400), or rabbit anti-caspase 3 active (EMD Millipore, AB3623; 1:200). Slides were washed 
five times for 10 min each in TBS + 0.2% Tween 20 at room temperature with gentle shaking, followed by sec-
ondary antibody goat-anti-rabbit-Alexa 555, goat-anti-mouse-Alexa 555 or goat-anti-rabbit-Alexa 488 (1:1,000; 
Molecular Probes) for 1 hour at room temperature in TBS + 5% BSA + 0.1% Tween-20 in the dark. After seven 
washes of 10 min each in TBS + 0.2% Tween 20 at room temperature with gentle shaking in the dark, samples 
were mounted with Diamond ProLong with DAPI. Images of the staining were taken using a confocal micro-
scope Nikon Eclipse Ti using a 20x objective (for HtrA1 quantification) or a Zeiss LSM 880 Airyscan confocal 
microscope using a 20x or 63x objective (all other staining). Brightness was equally adjusted per antibody after 
image acquisition for display purposes only. For high magnification images of chondrocytes in situ, a z-stack was 
obtained, and a Z project using Maximum intensity was generated. Pictures were acquired with a resolution of 
1024 × 1024 or above and 16-Bit.
HtrA1+ cells quantification. Confocal images were obtained from each sample (undamaged and damaged 
areas) from each patient, resulting in a total of N = 52 images for OA-only and N = 43 images for DDH-OA 
(details in Supplementary Tables 1 and 2). Images were analyzed in ImageJ. To subtract background fluorescence 
before cell counting, the threshold was determined per each image using the corresponding negative controls 
3Scientific RepoRtS |          (2020) 10:627  | https://doi.org/10.1038/s41598-020-57431-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
where the primary antibody was omitted. Cell counting was performed in thresholded images using DAPI 
nuclear counterstain as reference for identifying cells. To account for differences in cellularity between samples, 
we calculated the percentage of HtrA1+ cells rather than taking fluorescence intensity. Total cells per image were 
counted using DAPI staining. The percentage of HtrA1+ cells calculated. Counts were done by two blind investi-
gators. Mean values of % HtrA1+ cells and MMS were used for statistical analysis.
Chondrocyte isolation and gene expression analysis. Minced cartilage from undamaged and 
damaged areas of the hips was incubated for 30 min in 0.2% Pronase (Roche) followed by 17 hours of incuba-
tion in 0.2% Collagenase D (Roche) prepared in high glucose DMEM with sodium pyruvate and glutamate 
(Sigma) + 10% heat-inactivated Fetal bovine serum (Sigma) + 1x Antibiotic-Antimycotic (Gibco) + 50 µg/ml 
ascorbic acid. Cells were passed through a 100 µm strainer, washed with PBS, counted and used for RNA isola-
tion with Qiazol (Qiagen), following manufacturer’s instruction. Ratio 260/230 and 260/280 was obtained with 
NanoDrop One. 500 ng of total RNA were used for cDNA synthesis with iScript cDNA synthesis kit (Bio-Rad). 
One µl of this reaction was used for qPCR with SsoFast Eva Green qPCR kit (Bio-Rad). For gene expression anal-
ysis, we calculated 2(−ΔCt) using 18 s as housekeeping gene. Human primers for HtrA1, 18 s, and IL-1β were from 
QuantiTect Primer assay (Qiagen). Results are shown as relative quantity (RQ) to 18 s.
Statistical analysis. Local regression along with the Loess nonparametric method of fitting was used in esti-
mating the local weighted regression surface (via weighted least squares) for the relationship between the mean 
HtrA1+ cells (%) and cartilage degeneration (mean MMS) in the OA-only images (total N = 52 obtained from 13 
patients) and, separately, in the DDH-OA images (total N = 43 obtained from 9 patients). Specifically, this Loess 
fitting was based on local quadratic regression with a weighting kernel that was tricubic within a smoothing 
parameter span of 1.0 (for the OA-only sample) and 0.872 for the DDH-OA sample (100% and 87.2% around 
the point of prediction, respectively). The Loess curves for OA-only and DDH-OA resulted in different empirical 
patterns, therefore, Spearman correlation coefficient (rs) was estimated based on the empirical patterns and not 
on the pathological condition of the sample. The inter-rater reliability (using the ICC) between the two raters of 
MMS on the same OA-only samples was 0.910 (95% CI: 0.826 to 0.951) and on the same DDH-OA samples was 
0.929 (95% CI: 0.871 to 0.962). The inter-rater reliability (using the ICC) between the two raters’ HtrA1+ counts 
on the same OA-only samples was 0.860 (95% CI: 0.749 to 0.921) and on the same DDH-OA samples was 0.915 
(95% CI: 0.842 to 0.954). We used the mean of the two raters’ HtrA1+ counts and MMS in the analysis. Analyses 
were carried out using SAS software, version 9.4 (SAS Institute, Inc., Cary, NC, USA). The level of significance 
was set at α = 0.05 (two-tailed).
Finally, to compare % of HtrA1+ cells in undamaged OA-only versus damaged OA-only, we performed a 
paired Student’s t-test, with level of significance set as α = 0.05 (two-tailed). To compare % of HtrA1+ cells in 
undamaged OA-only versus undamaged DDH-OA, we performed an unpaired Student’s t-test, with level of sig-
nificance set as α = 0.05 (two-tailed). For the relationship between HtrA1+ cells with age of patient, and cellularity 
of tissue, we performed Pearson’s correlation analysis. To compare for differences in gene expression of IL1-β and 
HtrA1 in the four groups, we performed a one-way ANOVA with Fisher’s LSD as post-hoc. Level of significance 
was set as α = 0.05. These analyses were done in GraphPad Prism 8.
Results
Relationship between HtrA1 and cartilage damage in OA-only samples. We collected samples 
from areas with no visible fibrillation and cartilage from areas with fibrillation in the OA-only patient group 
(Fig. 1A). From this group we obtained only undamaged cartilage from 2 patients, only damaged cartilage from 4 
patients and both undamaged and damaged cartilage from 7 patients (Supplementary Table 1).
By first analyzing these samples as a patient independent pool, we were able to cover a range of OA severity, 
estimated by tissue damage using proteoglycan staining with Safranin O, and a MMS score (Fig. 1B). HtrA1 
immunostaining appeared mostly located at the superficial and middle layers of cartilage (Fig. 1C). There was 
almost no detectable staining in the deeper zone (Supplementary Fig. S1). By using co-staining with actin, we 
determined that HtrA1 was mostly intracellular (Fig. 1D,E).
We performed a local weighted regression with Loess fitting to identify the relationship between the percent-
age of HtrA1+ cells and the MMS. The empirical pattern obtained by Loess curve revealed a relatively flat rela-
tionship with MMS from 0 to 3, but it was followed by an increasing positive linear relationship when MMS were 
greater than 3 (Fig. 1F). Therefore, we calculated conditional correlation coefficients for the groups with MMS 
from 0 to 3, and then when they were 3.5 to 10. The estimated Spearman correlation coefficient was rs = −0.3076 
(p = 0.2143) for scores between 0–3 (N = 18 images, from 7 patients) and rs = 0.6589 (p < 0.0001) for MMS 
between 3.5–10 (N = 34 images, from 12 patients), demonstrating a low percentage of HtrA1+ cells in cartilage 
with no histological manifestation of OA and a high percentage in damaged cartilage. These results demonstrate 
that greater cartilage degeneration during the development of OA, as measured by MMS > 3, is related to a greater 
percentage of HtrA1+ cells, while in tissues with no histological manifestation of OA, the expression of HtrA1+ 
is low. Similarly, when cartilage images were analyzed as patient-dependent, we observed a lower percentage of 
HtrA1+ cells in undamaged cartilage compared to damaged cartilage from the same patient (p = 0.0021, Student’s 
t-test) (Fig. 1G).
We next analyzed whether the percentage of HtrA1+ cells depended on factors such as age, cellularity of tis-
sue, and proteoglycan content. We did not find any apparent relationship with any of these factors in this study 
(Fig. 2A,B). While proteoglycan staining was inversely related to the MMS, we found that in samples with com-
parable percentage of HtrA1+ cells, the proteoglycan content varied widely (Fig. 2C).
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Relationship between MMP13 staining, cell death and loss of aggrecan and collagen II and car-
tilage damage in oA-only samples. In order to characterize, more specifically, the nature of any changes 
in the cartilage obtained, we investigated the distribution of the two main cartilage ECM macromolecules, colla-
gen II and aggrecan (protein component of proteoglycans), and chondrocyte cell death, using IHC.
Aggrecan and collagen II staining was strong in undamaged cartilage, but less in damaged OA-only cartilage 
(Fig. 3A,B, panel i-iv). In contrast, both HtrA1 (Fig. 3A,B, panel v-vi) and MMP13 (Fig. 3A,B, panel vii-viii) 
showed a reverse pattern of staining (high in damaged cartilage). To investigate chondrocyte death IHC of the 
cleaved (active) form of caspase-3 was performed. The results showed that there was an increase in caspase-3 
active staining in damaged OA-only samples compared to undamaged cartilage (Fig. 3A,B, panel ix-x). The stain-
ing of deeper areas of cartilage are shown in Supplementary Fig. S1.
Relationship between HtrA1 and cartilage damage in DDH-OA samples. We collected DDH-OA 
cartilage from undamaged and damaged areas (Fig. 4A,B). From this group we obtained only damaged cartilage 
from 2 patients and both undamaged and damaged cartilage from 7 patients (Supplementary Table 2). A graph 
comparing MMS for undamaged and damaged DDH-OA with OA-only is shown in Fig. 4C. Summarized statis-
tics of MMS for both groups are shown in Supplementary Table 3 and 4. Tissue immunofluorescence of DDH-OA 
cartilage indicated that HtrA1 staining was increased in the surface and middle layers of the cartilage, similar 
to that seen in OA-only samples (Fig. 4D and Supplementary Fig. S1), primarily intracellular staining (Fig. 4E).
The local weighted regression with Loess fitting revealed a cubic relationship between the percentage of 
HtrA1+ cells and MMS in DDH-OA samples (Fig. 4F). Specifically, the empirical pattern of the Loess curve for 
DDH-OA showed a growing positive relationship between the percentage of HtrA1+ cells and MMS from 0 to 4.5, 
different from OA-only cartilage where the positive relationship was observed between MMS 3.5 to 10 (Fig. 4F). 
Therefore, we calculated the conditional correlation in the group with MMS from 0 to 4.5, and found an estimated 
Spearman correlation coefficient of rs = 0.8856 (p < 0.0001) (N = 24 images, from 7 patients).
When we analyzed images as patient-dependent, we found that the percentage of HtrA1+ cells in undam-
aged DDH-OA was similar to damaged DDH-OA samples (Fig. 4G. Student’s t-test, p = 0.1289), indicating that 
HtrA1 upregulation was present even in less damaged cartilage in DDH-OA preceding histological changes. 
Figure 1. Percentage of HtrA1+ cells increases with degeneration in OA-only samples. (A) Representative 
images of femoral heads indicating undamaged areas (blue arrow) and damaged areas (white arrows). (B) 
Proteoglycan visualized with Safranin-O staining of undamaged area with MMS of 2.5 and a damaged area with 
MMS of 10. Scale bar is 200 µm. (C) HtrA1 immunostaining (red) showing HtrA1+ cells in a sample with MMS 
of 2.5 (undamaged) compared to a sample with MMS of 10 (damaged). DAPI was used as nuclear counterstain 
(blue). Lower panel shows negative controls where primary antibody was omitted, DAPI was used as nuclear 
staining. Scale bars in C are 200 µm. (D) Higher magnification image showing HtrA1 in red and nucleus in blue 
from the same undamaged and damaged samples from (C). Scale bars in D are 10 µm. (E) Higher magnification 
of HtrA1 (red) co-stained with Actin (green) and DAPI (nucleus, blue) showing intracellular HtrA1. Scale bars 
in E are 10 µm. (F) Local weighted regression with Loess fitting for the relationship between % HtrA1+ cells and 
MMS. Results shown as mean values with 95% confidence limits for the regression surface (blue area). N = total 
52 images taken from 13 patients. (G) Paired comparison of % HtrA1+ cells between undamaged and damaged 
cartilage from OA-only samples. *Indicates a significant difference in a paired Student’s t-test with p = 0.0021. 
Data shown as mean of 2 blind counts. N = 16 pairs of images from 8 patients.
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The percentage of HtrA1+ cells was significantly higher in undamaged DDH-OA than in undamaged OA-only 
(Fig. 4H, Student’s t-test, p < 0.0001).
RNA obtained from OA-only and DDH groups were analyzed for HtrA1 gene expression. Results show no 
significant differences between any of the groups (Supplementary Fig. S2A). HtrA1 mRNA did not correlate with 
the percentage of HtrA1+ cells (Supplementary Fig. S2B). Similar to what was observed for OA-only samples, 
we did not find any relationship between the percentage of HtrA1+ cells with age, cellularity, and proteoglycan 
content (Supplementary Fig. 2C–E).
Relationship between MMP13 staining, cell death and loss of aggrecan and collagen II and car-
tilage damage in DDH-oA samples. Since chondrocytes in undamaged DDH-OA cartilage resembled 
damaged OA-only in the matrix protease HtrA1 expression, we investigated aggrecan and collagen II IHC. There 
was positive staining for both aggrecan and collagen II in undamaged DDH-OA cartilage. As expected with car-
tilage degeneration, the staining for both proteins was less in damaged DDH-OA cartilage (Fig. 5A,B, panel i-iv). 
HtrA1+ cells were detected in both undamaged and damaged DDH-OA samples (Fig. 5A,B, panel v-vi). MMP13 
staining in undamaged DDH-OA was greater compared to undamaged OA-only; however, MMP13 staining in 
damaged DDH-OA cartilage was low (Fig. 5A,B, panel vii-viii). The analysis of cell death by staining for cleaved 
caspase-3 active revealed the presence of few apoptotic cells in undamaged DDH-OA cartilage (Fig. 5A,B, panel 
ix-x). Staining of all these antibodies in deeper areas of cartilage are shown in Supplementary Fig. S3).
Signs of chondrocyte mechanical stress present in oA cartilage were observed in undamaged 
DDH-oA cartilage. Since there was evidence of ECM remodeling, but a lack of significant histological 
matrix degeneration in undamaged DDH-OA cartilage, we investigated whether there were any changes in the 
cytoskeleton in chondrocytes in undamaged DDH-OA cartilage. Vimentin intermediate filaments are critical for 
chondrocyte structural mechanics and accumulate under higher mechanical stress. IHC for vimentin revealed 
stronger fluorescence intensity in chondrocytes from the surface and middle layers in damaged OA-only cartilage 
when compared to chondrocytes from undamaged cartilage from the same patient (Fig. 6A). Similar to that seen 
for HtrA1 IHC, higher levels of vimentin staining was observed in undamaged DDH-OA cartilage (Fig. 6B).
Analysis of higher magnification images revealed thicker vimentin intermediate filament network in chondro-
cytes from undamaged DDH-OA cartilage resembling more those in damaged OA-only with higher MMS, than 
undamaged OA-only (Fig. 6C).
Qualitative analysis of confocal images of the mechanosensor protein, integrin α5β1, showed that although 
staining was present in undamaged OA-only samples and more in damaged OA-only, we observed that both 
undamaged and damaged DDH-OA cartilage had cells positive for this integrin more frequently found 
Figure 2. No relationship between the percentage of HtrA1+ cells and the age of patient, cellularity, or 
proteoglycan content. (A) Graph showing no apparent relationship between % HtrA1+ cells and age of patients. 
Results presented as mean per patient per condition (undamaged and damaged) with SD. N = 52 images from 
13 patients. (B) Graph showing no relationship between % HtrA1+ cells and cellularity of tissue measured as 
total cell number per image. Results presented as mean of 2 blind counts. Error bars were omitted for clarity. 
N = 52 images from 13 patients. (C) Representative images of OA-only samples stained for Proteoglycan content 
with Safranin-O. Percentage of HtrA1+ cells shown. Scale bars are 200 µm.
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throughout the tissue (Fig. 6D). In all samples, the distribution of integrin α5β1 was spread throughout the 
cartilage depth (Fig. 6D). Integrin α5β1 staining had some clustering at the cell periphery in all samples (Fig. 6E).
Gene expression analysis in OA-DDH versus OA-only cartilage. To seek whether activation of an 
inflammatory pathway in DDH-OA chondrocytes could have upregulated HtrA1 and MMP13 staining observed 
in this study, we investigated the mRNA expression of the pro-inflammatory cytokine IL-1β. The comparison 
between the four study-groups did not reveal statistical significance between the groups (Fig. 6G).
Discussion
In this study, we show evidence that changes are seen at the chondrocyte level in hip cartilage from patients with 
DDH, a disorder that leads to abnormal forces in the hip, before detectable changes in structure of the cartilage. 
Using aggrecan and collagen II IHC staining (in addition to standard histological techniques) we have shown that 
undamaged DDH cartilage has minimal ECM changes but that an upregulation of the serine protease HtrA1, 
reorganization of vimentin intermediate filaments that influence chondrocyte mechanical stability, and more 
staining of cells with clusters of the mechanosensor integrin α5β1 is detected. These findings indicate that changes 
in chondrocytes precede ECM degeneration in DDH, leading us to propose that undamaged cartilage obtained 
from DDH patients may be considered as a model to study early OA changes.
Hips from DDH patients have an increase in medially directed forces, resulting in altered joint reaction 
forces32, with focal increases in stress at a primary point of contact between the femoral head and the acetabu-
lum6 in comparison to more evenly distributed forces seen in the normal hip33. Contrary to what we observed 
for undamaged OA-only cartilage, undamaged DDH-OA cartilage had a higher percentage of HtrA1+ cells, even 
though there was no apparent surface fibrillation or proteoglycan loss. This observation was the first indication 
that in undamaged DDH-OA cartilage, chondrocytes are responding to a mechanical stresses prior to detectable 
histological manifestations.
Figure 3. Loss of ECM proteins and increase in proteases staining in damaged OA-only samples. (A) Panel 
showing an undamaged OA-only sample with MMS 2.5 stained for Aggrecan (i, red), Collagen II (ii, green), 
overlay (iii), overlay with DAPI (iv), HtrA1 (v, red), HtrA1 + DAPI (vi), MMP13 (vii, red), MMP13 + DAPI 
(viii), Caspase-3 active (ix, red), Caspase-3 active + DAPI (x) with inset for cells in higher magnification, No 
primary control (xi, red), and No primary control + DAPI (xii). Only Aggrecan and Collagen II were co-stained 
on the same sample. The images for the other antibodies’ staining are in equivalent areas. (B) Same array 
of panels for a damaged OA-only sample with MMS 10. Scale bars are 200 µm. Images were taken with 20x 
objective.
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In this study, HtrA1 has been investigated because of its role regulating the TGFβ pathway and cleaving 
fibronectin16,34, two events that influence cartilage pathophysiology17,35 and HtrA1 has been associated with OA 
in a number of reports16,19–23, including evidence for early upregulation during cartilage degeneration21. We first 
investigated changes in HtrA1 protein expression in situ, in cartilage samples with a range of cartilage degenera-
tion degree. In normal cartilage, HtrA1 protein is located intracellularly, with most detected in surface and mid-
dles zone chondrocytes, as reported previously in knee and temporomandibular cartilage in animal models20,21 
and human hip cartilage19. In our study, HtrA1 first appeared in cartilage with minor damage, indicating that 
HtrA1 expression is an early event in the progression of OA, which has been previously suggested21. We did not 
find a relationship between HtrA1 gene expression and the percentage of HtrA1+ cells; therefore, we propose that 
changes in HtrA1 are likely due to a decrease in protein degradation rather than synthesis de novo. Factors that 
could affect HtrA1 expression are age, tissue cellularity, and proteoglycan content. Previous studies have linked 
HtrA1 with an inhibition of proliferation36; however, we did not find any relationship with cellularity in this study. 
Nor did we find an association of intracellular HtrA1 with age or with proteoglycan content in the cartilage. It 
has been shown that HtrA1 cleavage of aggrecan generates a new epitope and that this epitope is more abundant 
in knee cartilage from OA patients, indicating that HtrA1 may have a crucial role in proteoglycan integrity in 
OA19. A limitation to our study is that we did not account for any exported HtrA1, so we can only conclude that 
the loss in proteoglycan per se is not related to the increase in the intracellular subpopulation of HtrA1. Another 
limitation is our small number of subjects. Sex is also a potential factor that may affect HtrA1— although this 
relationship has not been previously established or reported. The current study did not evaluate a gender effect; 
Figure 4. Increase in percentage of HtrA1+ cells observed in undamaged DDH-OA samples. (A) 
Representative images of femoral heads indicating undamaged areas (blue arrow) and damaged areas (white 
arrows). (B) Safranin-O staining of an undamaged DDH-OA sample with MMS of 2.5 and a damaged DDH-OA 
samples with MMS of 4.5. (C) Graph showing comparison between MMS of OA-only versus DDH-OA for 
the undamaged (green symbols) and the damaged (orange symbols) groups. Data shown as mean ± SD of two 
independent raters. (D) Representative confocal images of HtrA1 staining to show HtrA1+ cells in undamaged 
versus damaged DDH-OA cartilage. DAPI was used as a nuclear counterstain. Lower panel is negative control 
where the primary antibody was omitted. Scale bars are 200 µm. (E) Higher magnification images of HtrA1 in 
chondrocytes in situ in undamaged and damaged DDH-OA cartilage. Scale bars are 10 µm. (F) Local weighted 
regression with Loess fitting for the relationship between % HtrA1+ cells and MMS. Results shown as mean 
values with 95% confidence limits for the regression surface (blue area). N = 43 images from 9 patients. (G) 
Graph of paired observations showing no significant difference between % of HtrA1+ cells in undamaged versus 
damaged DDH-OA cartilage. Student’s t-test p = 0.1289 (two-tailed). Results shown as mean of 2 blind counts. 
N = 19 pairs of images from 7 patients. (H) Unpaired comparison of % HtrA1+ cells between undamaged 
OA-only and undamaged DDH-OA cartilage samples. *Indicates significant difference in unpaired Student’s 
t-test with p < 0.0001. Results shown as mean of 2 blind counts with SD. N = 24 images from 9 patients for 
undamaged OA-only; N = 21 images from 7 patients for damaged DDH-OA.
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however, evaluating sex as another potential salient factor for this protein will require a larger sample size and 
could be a focus of future research.
Vimentin intermediate filaments are essential components of the chondrocyte cytoskeleton and are upregu-
lated in response to mechanical stress9,10,37,38, up to tissue damaging stress where vimentin networks can break and 
disassemble39. Both OA and DDH-OA cartilage experience abnormal loading32,40. When cartilage suffers injury, 
the extracellular matrix components such as proteoglycan and collagen fibers lose the arrangement that allows 
them to withhold water and to regulate hydrostatic pressure40,41 affecting chondrocyte load. Deformation result-
ing from compression is higher at the surface and middle layers of cartilage42, and since the mechanical properties 
of ECM are altered in OA, mechanical loading of chondrocytes can be exacerbated. To evaluate whether the struc-
tural mechanics of chondrocytes was affected by the abnormal mechanics experienced in DDH-OA cartilage, we 
investigated changes in vimentin filaments arrangement. Our results revealed that vimentin filaments organized 
into thicker networks as cartilage degradation advanced, with the most robust staining predominantly located at 
the surface and middle layers. This pattern, similar to HtrA1 staining, was located in areas that are predicted to 
be the most deformed under compression forces42. Interestingly, the same reorganization of vimentin filaments 
was detected in undamaged DDH-OA cartilage, indicating a cellular response to a common stimulation in both 
damaged OA cartilage and undamaged DDH-OA cartilage.
To further study cellular responses to mechanical changes in cartilage, we evaluated integrin α5β1. This inte-
grin is the primary receptor for fibronectin and can also function as a mechanoreceptor43,44. During the pro-
gression of OA, chondrocytes experience changes in integrin expression45–47. Since integrin α5β1 binds not only 
regular fibronectin but also fibronectin fragments, depending on the ongoing physiological process, its activation 
can result in a detrimental physiological response18,48 or a positive one, promoting cell survival49. Although there 
are reports of the upregulation of integrin α5β1 in OA46, there is a lack of a detailed analysis of integrin clustering 
in chondrocytes in situ as a response to the progression of OA. Here we found that integrin α5β1 forms small 
Figure 5. Signs of remodeling but not of significant ECM degradation were detected in undamaged DDH-OA 
samples. (A) Panel showing an undamaged DDH-OA sample with MMS 2.5 stained for Aggrecan (i, red), 
Collagen II (ii, green), overlay (iii), overlay with DAPI (iv), HtrA1 (v, red), HtrA1 + DAPI (vi), MMP13  
(vii, red), MMP13 + DAPI (viii), Caspase-3 active (ix, red), Caspase-3 active + DAPI (x) with inset for cells in 
higher magnification, No primary control (xi, red), and No primary control + DAPI (xii). Only Aggrecan and 
Collagen II were co-stained on the same sample. The images for the other antibodies’ staining are in equivalent 
areas. (B) Same array of panels for a damaged DDH-OA sample with MMS 4.5. Scale bars are 200 µm. Images 
were taken with 20x objective.
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Figure 6. Additional signs of osteoarthritic pathological phenotype of chondrocytes were detected in 
undamaged DDH-OA samples. (A) Vimentin intermediate filaments staining (green) of an undamaged and a 
damaged OA-only sample. DAPI was used as nuclear counterstain. (B) Vimentin (green) and DAPI staining 
of undamaged and damaged DDH-OA cartilage. (C) Images of vimentin + DAPI staining in chondrocytes 
in situ showing that undamaged DDH-OA samples have more vimentin staining than undamaged OA-only 
with the same MMS and is more comparable to samples of damaged OA-only with higher MMS. MMS are 
indicated in the upper left corner of each picture. (D) Integrin α5β1 (red) + DAPI staining of all groups. Surface 
and middle layers are shown. White arrows indicate examples of positive cells throughout cartilage depth. (E) 
Images of chondrocytes in situ from samples in D. White arrows indicate integrin α5β1 clustering. (F) Integrin 
α5β1 staining in deep layers of undamaged OA-only and undamaged DDH-OA cartilage. White arrows indicate 
examples of positive cells. (G) mRNA expression of IL-1β in the 4 groups of samples. No significant differences 
were detected between the groups. Values are shown as relative quantity (RQ) to 18 s in Log10 scale for better 
display. Lines represent average. Scale bars for A, B, D, and F are 200 µm. Scale bars for C and E are 10 µm.
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clusters in chondrocytes in situ in OA cartilage and in DDH-OA cartilage, and that these clusters are more fre-
quently found in undamaged DDH-OA cartilage.
The activation of inflammatory cascades is one of the factors that may contribute to cartilage degeneration, 
although there is no evidence that inflammation is related to DDH. Since upregulation of MMP13 can occur as 
response to pro-inflammatory cytokines such as IL-1β50, we investigated whether DDH-OA cartilage had higher 
expression of this cytokine. Interestingly, we did not find significant differences in mRNA expression of IL-1β 
between the four groups studied here, however, it is important to acknowledge that our sample number is low. 
Therefore, we can only conclude that for the samples analyzed in this study, chondrocytes do not upregulate IL-1β 
in DDH-OA.
Since DDH hips are exposed to abnormal mechanical load, we propose that the thickening of vimentin fila-
ments and the accumulation of integrin α5β1 at the cell periphery represents a response to changes in mechanical 
stimulation prior to histological changes in the cartilage. Tissue structural factors can affect the cell’s perception of 
mechanical stimulation and its mechanotransduction51. Studies on biophysical characterization of the ECM in OA 
cartilage have shown that collagen fibers undergo stiffening, due to increased fiber cross-linking directly affecting 
the elasticity of the ECM52,53. This higher matrix stiffness translates into activation of the Rho-ROCK-MLC path-
way and increased formation of focal adhesions54. Higher matrix stiffness also affects polymerization of vimentin 
filaments, leading to a thicker network55. Moreover, it has been shown that vimentin stabilizes focal adhesions 
when endothelial cells are exposed to shear stress56 and that fibroblasts from vimentin-null mice have more irreg-
ular and less mechanically stable focal contacts57 (reviewed in58). This evidence, together with the lack of IL-1β 
upregulation in chondrocytes, suggests that the histological changes that we observed for both vimentin and 
integrin α5β1 are likely due to alterations at the mechanical environment.
Interestingly, MMP13 not only increases with IL-1β, but there is evidence that mechanical induction is also 
involved in its upregulation59,60, and in fact MMP13 is upregulated early in a rat model for DDH29, with a sim-
ilar staining pattern to the one we observed. We detected more MMP13 in undamaged DDH-OA compared to 
undamaged OA-only, and both samples had similar aggrecan and collagen II staining, indicating that the increase 
in MMP13 is an early event, like that observed in a rat model for DDH29. We propose that there is an early induc-
tion of matrix turnover by MMP13 and possibly HtrA1. This supports the hypothesis of microstructural changes 
in the immediate chondrocyte niche that affect their internal microstructure.
The results in this study suggest that physiological changes occur early in chondrocytes, before histological 
manifestations of OA. We propose that these changes are a response to an altered chondrocyte microenviron-
ment. Moreover, our lack of evidence for inflammatory involvement leads us to further propose that mechanical 
changes are likely to be responsible for the pathological phenotype observed in chondrocytes. Although more 
research is required to empirically test this hypothesis, this DDH cartilage environment provides a novel oppor-
tunity to study early events of OA and provide a possible opportunity for the developments of therapeutic targets 
for OA.
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